139.97 USD
+0.77 (+0.55%)
139.97 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 84% to NTES. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 164.55. This target is 17.56% above the current price.
NTES was analyzed by 36 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about NTES.
In the previous month the buy percentage consensus was at a similar level.
NTES was analyzed by 36 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-21 | Guggenheim | Maintains | Buy -> Buy |
| 2025-11-21 | Benchmark | Maintains | Buy -> Buy |
| 2025-11-21 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-10-10 | JP Morgan | Upgrade | Neutral -> Overweight |
| 2025-08-18 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-07-28 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-05-19 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-05-16 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-02-24 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-02-21 | Benchmark | Maintains | Buy -> Buy |
| 2025-02-12 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-01-15 | B of A Securities | Maintains | Buy -> Buy |
| 2025-01-08 | Morgan Stanley | Upgrade | Equal-Weight -> Overweight |
| 2024-11-15 | Benchmark | Maintains | Buy -> Buy |
| 2024-11-15 | Citigroup | Maintains | Buy -> Buy |
| 2024-08-26 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2024-08-23 | B of A Securities | Maintains | Buy -> Buy |
| 2024-08-22 | Jefferies | Maintains | Buy -> Buy |
| 2024-07-05 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2024-06-27 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2024-06-13 | Barclays | Initiate | Equal-Weight |
| 2024-05-24 | Benchmark | Maintains | Buy -> Buy |
| 2024-05-23 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2024-04-24 | HSBC | Maintains | Buy -> Buy |
| 2024-04-12 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023-11-17 | Benchmark | Maintains | Buy -> Buy |
| 2023-08-29 | JP Morgan | Maintains | Overweight -> Overweight |
| 2023-08-25 | Benchmark | Maintains | Buy -> Buy |
| 2023-08-25 | B of A Securities | Maintains | Buy -> Buy |
| 2023-08-25 | Citigroup | Maintains | Buy -> Buy |
NETEASE INC-ADR / NTES FAQ
What is the average price target for NETEASE INC-ADR (NTES) stock?
36 analysts have analysed NTES and the average price target is 164.55 USD. This implies a price increase of 17.56% is expected in the next year compared to the current price of 139.97.
What is the consensus rating for NTES stock?
The consensus rating for NETEASE INC-ADR (NTES) is 83.8889 / 100 . This indicates that analysts generally have a positive outlook on the stock.
Can you provide the analyst count for NETEASE INC-ADR stock?
The number of analysts covering NETEASE INC-ADR (NTES) is 36.